Controversial roles played by toll like receptor 4 in urinary bladder cancer; A systematic review
Life Sciences, ISSN: 0024-3205, Vol: 158, Page: 31-36
2016
- 20Citations
- 18Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations20
- Citation Indexes20
- 20
- CrossRef6
- Captures18
- Readers18
- 18
- Mentions1
- Blog Mentions1
- 1
Most Recent Blog
The TLR4-Active Morphine Metabolite Morphine-3-Glucuronide Does Not Elicit Macrophage Classical Activation In Vitro
Introduction Opioids still play a major role in perioperative patient care, however, they are reported to modulate tumor growth and metastasis, with discrepant evidence from both in vitro and in vivo experimental settings (Afsharimani et al., 2011, 2015). Reprogramming TAMs from an M2-like phenotype to an M1-like, pro-inflammatory phenotype has the potential to induce anti-tumor activity by render
Review Description
Urinary bladder cancer (UBC) is a prevalent human cancer. The main mechanisms which lead to eradication or progression the disease has yet to be clarified. Toll like receptor (TLR) 4 is a membrane receptor which is expressed either on immune cells or tumor cells. This review article was aimed to clear the main mechanisms played by TLR4 and its related intracellular pathways on outcome of UBC. PubMed, Scopus and Google scholar databases have been used for searching related research articles which have evaluated the roles played by TLR4 and its related intracellular pathways on outcome of UBC. Collected information from the related articles revealed that TLR4 either participates in induction of immune responses against UBC or development of the malignancy. There are limited investigations regarding the genetic variations of TLR4 in UBC. According to the results it seems that TLR4/ligands interaction outcome is dependent on several factors including TLR4 ligand doses, interaction of TLR4 with its ligands on immune cells or tumor cells, and other TLRs/ligand interaction simultaneously.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0024320516303691; http://dx.doi.org/10.1016/j.lfs.2016.06.013; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84975847396&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/27316642; https://linkinghub.elsevier.com/retrieve/pii/S0024320516303691; https://dx.doi.org/10.1016/j.lfs.2016.06.013
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know